Back to Trials
NCT05672368PHASE2Recruiting

The da Vinci Single Port Robotic System for Use in Abdominal and Pelvic Surgical Procedures

City of Hope Medical Center

Start Date

4/26/2024

Completion Date

10/13/2026

Summary

This phase II trial test the effectiveness and safety of a single-port robotic device (the da Vinci single port \[SP\]1098) for use in abdominal and pelvic surgeries. The da Vinci SP1098 robotic device can be used to perform less invasive surgeries that allow entry into the body through a single, small incision. The use of this device during surgery may allow surgeons to perform complex procedures that result in less pain, fewer complications and side effects, and improved recovery.

Detailed Description

PRIMARY OBJECTIVE: I. To evaluate the effectiveness and safety for abdominal and pelvic procedures of a single-port robotic device (da Vinci SP1098) that is Food and Drug Administration (FDA)-approved for other indications, specifically urological and transoral otolaryngology surgical procedures. OUTLINE: Patients undergo surgery using the da Vinci SP1098 robotic system on study.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Documented informed consent of the participant and/or legally authorized representative * Any patient scheduled to undergo robot-assisted abdominal or pelvic procedures * Age \> 18 years Exclusion Criteria: * Body mass index (BMI) \> 45 * Contraindications to minimally invasive surgery including chronic obstructive pulmonary disorders * Past history of failed attempt of minimally invasive abdominal or pelvic surgery

Interventions

DEVICE

Robot-Assisted Surgery

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Disease or Disorder

Locations

City of Hope Comprehensive Cancer Center

Duarte, California 91010

United States